# Cardiac Magnetic Resonance to Reclassify Diagnosis and Detect Cardiomyopathies in Hospitalized Patients with Acute Presentation

**Authors:** Theodoros Tsampras, Alexios Antonopoulos, Alexandros Kasiakogias, Alexia Mika, Antonia Kolovou, Eleni Papadimitriou, George Lazaros, Konstantinos Tsioufis, Charalambos Vlachopoulos

PMC · DOI: 10.3390/life15030470 · Life · 2025-03-15

## TL;DR

This study shows that cardiac MRI helps reclassify diagnoses and detect cardiomyopathies in hospitalized patients with acute heart issues.

## Contribution

The study demonstrates the high diagnostic yield of CMR in identifying cardiomyopathies in acutely hospitalized patients.

## Key findings

- 33% of hospitalized patients had CMR findings indicating underlying cardiomyopathy.
- CMR reclassified the initial diagnosis into cardiomyopathy in 32% of cases.
- Heart failure patients had the highest reclassification rate at 71%.

## Abstract

Background: Cardiomyopathies are a significant cause of heart failure, arrhythmia, and cardiac morbidity in the general population. Cardiovascular magnetic resonance (CMR) is a valuable tool for the diagnostic work-up of patients with acute cardiac events. Objectives: This study evaluated the diagnostic value of CMR and the yield of cardiomyopathies in hospitalized cardiac patients with acute presentation. Methods: A retrospective analysis was conducted with 535 consecutive hospitalized patients who underwent CMR at Hippokration Hospital, Athens, Greece, to identify a subset of scans performed on an urgent basis of hospitalized patients. Demographic data, causes of admission, CMR findings, and plasma cardiac biomarkers (hs-Troponin I, NT-proBNP, and CRP) were systematically recorded. Results: Out of the initial 535 CMR scans evaluated, a further analysis was conducted with 104 patients who were in hospital and underwent CMR on an urgent basis. From the total population of hospitalized patients, 33% had CMR findings indicative of underlying cardiomyopathy, with dilated cardiomyopathy being the most common subtype (36%), followed by arrhythmogenic cardiomyopathy (27%), hypertrophic cardiomyopathy (15%), or other subtypes (e.g., cardiac amyloidosis, sarcoidosis, endomyocardial fibrosis, EGPA, or unclassified). CMR led to the reclassification of the initial diagnosis into that of underlying cardiomyopathy in 32% of cases. The highest reclassification rate was observed within the subgroup with heart failure (71%), followed by that of acute myocardial infarction/ischemic heart disease (24%) and myocarditis (22%). Conclusions: CMR imaging effectively contributed to the differential diagnosis of hospitalized patients with acute cardiac events that remained without a definitive diagnosis after their initial work-up and uncovered underlying cardiomyopathy in almost one-third of this cohort.

## Linked entities

- **Diseases:** heart failure (MONDO:0005252), arrhythmia (MONDO:0007263), sarcoidosis (MONDO:0008399), endomyocardial fibrosis (MONDO:0006746), EGPA (MONDO:0015943), acute myocardial infarction (MONDO:0004781), ischemic heart disease (MONDO:0024644), myocarditis (MONDO:0004496)

## Full-text entities

- **Genes:** CRP (C-reactive protein) [NCBI Gene 1401] {aka PTX1}
- **Diseases:** heart failure (MESH:D006333), endomyocardial fibrosis (MESH:D004719), sarcoidosis (MESH:D012507), cardiac amyloidosis (MESH:D000686), arrhythmia (MESH:D001145), myocarditis (MESH:D009205), Cardiomyopathies (MESH:D009202), ischemic heart disease (MESH:D017202), dilated cardiomyopathy (MESH:D002311), acute myocardial infarction (MESH:D009203), arrhythmogenic cardiomyopathy (MESH:D019571), hypertrophic cardiomyopathy (MESH:D002312)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC11944084/full.md

## Figures

3 figures with captions in the complete paper: https://tomesphere.com/paper/PMC11944084/full.md

## References

45 references — full list in the complete paper: https://tomesphere.com/paper/PMC11944084/full.md

---
Source: https://tomesphere.com/paper/PMC11944084